These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 30136881)

  • 1. Adeno-associated virus 2 mediated gene transfer of vascular endothelial growth factor Trap: a new treatment option for glioma.
    Zhao S; Zhang Y; Wang L; Yang L; Zou L; Gao F
    Cancer Biol Ther; 2019; 20(1):65-72. PubMed ID: 30136881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of diffusion-weighted magnetic resonance imaging in the evaluation of the response to AAV2-VEGF-Trap neoadjuvant treatment in a triple-negative breast cancer animal model.
    Li J; Zhu P; Wang L; Yang L; Zou L; Gao F
    Cancer Med; 2019 Apr; 8(4):1594-1603. PubMed ID: 30900382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AAV2-mediated gene transfer of VEGF-Trap with potent suppression of primary breast tumor growth and spontaneous pulmonary metastases by long-term expression.
    Lu L; Luo ST; Shi HS; Li M; Zhang HL; He SS; Liu Y; Pan Y; Yang L
    Oncol Rep; 2012 Oct; 28(4):1332-8. PubMed ID: 22824831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of anti-VEGF therapy and temozolomide in two experimental human glioma models.
    Grossman R; Brastianos H; Blakeley JO; Mangraviti A; Lal B; Zadnik P; Hwang L; Wicks RT; Goodwin RC; Brem H; Tyler B
    J Neurooncol; 2014 Jan; 116(1):59-65. PubMed ID: 24185441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Far-infrared Ray on Temozolomide-treated Glioma in Rats.
    Chen JC; Hwang JH
    In Vivo; 2019; 33(4):1203-1208. PubMed ID: 31280210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic inhibition of angiogenesis and glioma cell-induced angiogenesis by the combination of temozolomide and enediyne antibiotic lidamycin.
    Li XQ; Ouyang ZG; Zhang SH; Liu H; Shang Y; Li Y; Zhen YS
    Cancer Biol Ther; 2014 Apr; 15(4):398-408. PubMed ID: 24424202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy of VEGF-trap and gemcitabine results in improved anti-tumor efficacy in a mouse lung cancer model.
    Zhou S; Yang Y; Yang Y; Tao H; Li D; Zhang J; Jiang G; Fang J
    PLoS One; 2013; 8(7):e68589. PubMed ID: 23874680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DCE and DW-MRI monitoring of vascular disruption following VEGF-Trap treatment of a rat glioma model.
    Hoff BA; Bhojani MS; Rudge J; Chenevert TL; Meyer CR; Galbán S; Johnson TD; Leopold JS; Rehemtulla A; Ross BD; Galbán CJ
    NMR Biomed; 2012 Jul; 25(7):935-42. PubMed ID: 22190279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling.
    Navone SE; Guarnaccia L; Cordiglieri C; Crisà FM; Caroli M; Locatelli M; Schisano L; Rampini P; Miozzo M; La Verde N; Riboni L; Campanella R; Marfia G
    World Neurosurg; 2018 Dec; 120():e380-e391. PubMed ID: 30144594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bevacizumab with angiostatin-armed oHSV increases antiangiogenesis and decreases bevacizumab-induced invasion in U87 glioma.
    Zhang W; Fulci G; Buhrman JS; Stemmer-Rachamimov AO; Chen JW; Wojtkiewicz GR; Weissleder R; Rabkin SD; Martuza RL
    Mol Ther; 2012 Jan; 20(1):37-45. PubMed ID: 21915104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined blockade of HER2 and VEGF exerts greater growth inhibition of HER2-overexpressing gastric cancer xenografts than individual blockade.
    Singh R; Kim WJ; Kim PH; Hong HJ
    Exp Mol Med; 2013 Nov; 45(11):e52. PubMed ID: 24176949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synergistic therapeutic effect of temozolomide and hyperbaric oxygen on glioma U251 cell lines is accompanied by alterations in vascular endothelial growth factor and multidrug resistance-associated protein-1 levels.
    Lu XY; Cao K; Li QY; Yuan ZC; Lu PS
    J Int Med Res; 2012; 40(3):995-1004. PubMed ID: 22906272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune modulation associated with vascular endothelial growth factor (VEGF) blockade in patients with glioblastoma.
    Thomas AA; Fisher JL; Hampton TH; Christensen BC; Tsongalis GJ; Rahme GJ; Whipple CA; Steel SE; Davis MC; Gaur AB; Lewis LD; Ernstoff MS; Fadul CE
    Cancer Immunol Immunother; 2017 Mar; 66(3):379-389. PubMed ID: 27942839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bevacizumab changes vascular structure and modulates the expression of angiogenic factors in recurrent malignant gliomas.
    Okamoto S; Nitta M; Maruyama T; Sawada T; Komori T; Okada Y; Muragaki Y
    Brain Tumor Pathol; 2016 Apr; 33(2):129-36. PubMed ID: 26826105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of bevacizumab on temozolomide concentrations in intracranial U87 gliomas.
    Grossman R; Rudek MA; Brastianos H; Zadnik P; Brem H; Tyler B; Blakeley JO
    Cancer Chemother Pharmacol; 2012 Jul; 70(1):129-39. PubMed ID: 22644796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YB-1 dependent virotherapy in combination with temozolomide as a multimodal therapy approach to eradicate malignant glioma.
    Holzmüller R; Mantwill K; Haczek C; Rognoni E; Anton M; Kasajima A; Weichert W; Treue D; Lage H; Schuster T; Schlegel J; Gänsbacher B; Holm PS
    Int J Cancer; 2011 Sep; 129(5):1265-76. PubMed ID: 21710499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma.
    Kaliberova LN; Krendelchtchikova V; Harmon DK; Stockard CR; Petersen AS; Markert JM; Gillespie GY; Grizzle WE; Buchsbaum DJ; Kaliberov SA
    Cancer Gene Ther; 2009 Oct; 16(10):794-805. PubMed ID: 19363468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roscovitine effectively enhances antitumor activity of temozolomide in vitro and in vivo mediated by increased autophagy and Caspase-3 dependent apoptosis.
    Pandey V; Ranjan N; Narne P; Babu PP
    Sci Rep; 2019 Mar; 9(1):5012. PubMed ID: 30899038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
    Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
    Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined targeting of interleukin-6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness.
    Saidi A; Hagedorn M; Allain N; Verpelli C; Sala C; Bello L; Bikfalvi A; Javerzat S
    Int J Cancer; 2009 Sep; 125(5):1054-64. PubMed ID: 19431143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.